Waylon J. Hastings

Waylon J. Hastings

Auto-generated profile, based on publicly available information

Waylon J. Hastings

Department of Psychiatry and Behavioral Sciences Tulane University School of Medicine New Orleans Louisiana USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Ageing Research Reviews
Verified
Journal Article
Closed access
QYQiaofeng Ye
Qiaofeng Ye
AAAbner T. Apsley
Abner T. Apsley
LELaura Etzel
Laura Etzel
WHWaylon J. Hastings
Waylon J. Hastings
JKJohn T. Kozlosky
John T. Kozlosky
ISIdan Shalev
Idan Shalev

9 January 2025 in Aging Cell
Verified
Journal Article
Open access
AAAbner T. Apsley
Abner T. Apsley
QYQiaofeng Ye
Qiaofeng Ye
ACAvshalom Caspi
Avshalom Caspi
CCChristopher Chiaro
Christopher Chiaro
LELaura Etzel
Laura Etzel
ISIdan Shalev
Idan Shalev
Epigenetic clocks are a common group of tools used to measure biological aging—the progressive deterioration of cells, tissues, and organs. Epigenetic clocks have been trained almost exclusively using blood‐based tissues, but there is growing interest in estimating epigenetic age using less‐invasive oral‐based tissues (i.e., buccal or saliva) in both research and commercial settings. However, differentiated cell types across body tissues exhibit unique DNA methylation landscapes and age‐related alterations to the DNA methylome. Applying epigenetic clocks derived from blood‐based tissues to estimate epigenetic age of oral‐based tissues may introduce biases. We tested the within‐person comparability of common epigenetic clocks across five tissue types: buccal epithelial, saliva, dry blood spots, buffy coat (i.e., leukocytes), and peripheral blood mononuclear cells. We tested 284 distinct tissue samples from 83 individuals aged 9–70 years. Overall, there were significant within‐person differences in epigenetic clock estimates from oral‐based versus blood‐based tissues, with average differences of almost 30 years observed in some age clocks. In addition, most epigenetic clock estimates of blood‐based tissues exhibited low correlation with estimates from oral‐based tissues despite controlling for cellular proportions and other technical factors. Notably, the Skin and Blood clock exhibited the greatest concordance across all tissue types, indicating its unique ability to estimate chronological age in oral‐ and blood‐based tissues. Our findings indicate that application of blood‐derived epigenetic clocks in oral‐based tissues may not yield comparable estimates of epigenetic age, highlighting the need for careful consideration of tissue type when estimating epigenetic age.

19 March 2024 in Aging Cell
Verified
Journal Article
Open access
PDF file
WHWaylon J. Hastings
Waylon J. Hastings
QYQiaofeng Ye
Qiaofeng Ye
SWSarah E. Wolf
Sarah E. Wolf
CRCalen P. Ryan
Calen P. Ryan
SDSai Krupa Das
Sai Krupa Das
ISIdan Shalev
Idan Shalev
Caloric restriction (CR) modifies lifespan and aging biology in animal models. The Comprehensive Assessment of Long‐Term Effects of Reducing Intake of Energy (CALERIE™) 2 trial tested translation of these findings to humans. CALERIE™ randomized healthy, nonobese men and premenopausal women (age 21–50y; BMI 22.0–27.9 kg/m2), to 25% CR or ad‐libitum (AL) control (2:1) for 2 years. Prior analyses of CALERIE™ participants' blood chemistries, immunology, and epigenetic data suggest the 2‐year CR intervention slowed biological aging. Here, we extend these analyses to test effects of CR on telomere length (TL) attrition. TL was quantified in blood samples collected at baseline, 12‐, and 24‐months by quantitative PCR (absolute TL; aTL) and a published DNA‐methylation algorithm (DNAmTL). Intent‐to‐treat analysis found no significant differences in TL attrition across the first year, although there were trends toward increased attrition in the CR group for both aTL and DNAmTL measurements. When accounting for adherence heterogeneity with an Effect‐of‐Treatment‐on‐the‐Treated analysis, greater CR dose was associated with increased DNAmTL attrition during the baseline to 12‐month weight‐loss period. By contrast, both CR group status and increased CR were associated with reduced aTL attrition over the month 12 to month 24 weight maintenance period. No differences were observed when considering TL change across the study duration from baseline to 24‐months, leaving it unclear whether CR‐related effects reflect long‐term detriments to telomere fidelity, a hormesis‐like adaptation to decreased energy availability, or measurement error and insufficient statistical power. Unraveling these trends will be a focus of future CALERIE™ analyses and trials.

30 January 2025 in Aging Cell
Verified
Journal Article
Open access
LSLisa J. Schmunk
Lisa J. Schmunk
TCToby P. Call
Toby P. Call
DMDaniel L. McCartney
Daniel L. McCartney
HJHira Javaid
Hira Javaid
WHWaylon J. Hastings
Waylon J. Hastings
DMDaniel E. Martin‐Herranz
Daniel E. Martin‐Herranz
Accessible and non‐invasive biomarkers that measure human ageing processes and the risk of developing age‐related disease are paramount in preventative healthcare. Here, we describe a novel framework to train saliva‐based DNA methylation (DNAm) biomarkers that are reproducible and biologically interpretable. By leveraging a reliability dataset with replicates across tissues, we demonstrate that it is possible to transfer knowledge from blood DNAm to saliva DNAm data using DNAm proxies of blood proteins (EpiScores). We apply these methods to create a new saliva‐based epigenetic clock (InflammAge) that quantifies systemic chronic inflammation (SCI) in humans. Using a large blood DNAm human cohort with linked electronic health records and over 18,000 individuals (Generation Scotland), we demonstrate that InflammAge significantly associates with all‐cause mortality, disease outcomes, lifestyle factors, and immunosenescence; in many cases outperforming the widely used SCI biomarker C‐reactive protein (CRP). We propose that our biomarker discovery framework and InflammAge will be useful to improve understanding of the molecular mechanisms underpinning human ageing and to assess the impact of gero‐protective interventions.

28 June 2021 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
WHWaylon J Hastings
Waylon J Hastings
DADavid M Almeida
David M Almeida
ISIdan Shalev
Idan Shalev
Indices quantifying allostatic load (AL) and biological aging (BA) have independently received widespread use in epidemiological literature. However, little attention has been paid to their conceptual and quantitative overlap. By reviewing literature utilizing measures of AL and BA, and conducting comparative analysis, we highlight similarities and differences in biological markers employed and approach toward scale construction. Further, we outline opportunities where both types of indices might be improved by adopting methodological features of the other. Using data from the National Survey of Midlife Development in the United States (N = 2055, age = 26–86), we constructed 3 AL indices: 1 common literature standard and 2 alternative formulations informed by previous work with measures of BA. The performance of AL indices was juxtaposed against 2 commonly employed BA indices: Klemera-Doubal Method Biological Age and Homeostatic Dysregulation. All indices correlated with chronological age. Participants with higher AL and older BA performed worse on tests of physical and subjective functioning. Further, participants with increased life-course risk exposure exhibited higher AL and BA. Notably, alternative AL formulations tended to exhibit effect sizes equivalent to or larger than those observed for BA measures, and displayed superior mortality prediction. In addition to their conceptual similarity, AL and BA indices also exhibit significant analytical similarity. Further, BA measures are robust to construction using a panel of biomarkers not observed in previous iterations, including carotenoids indexing antioxidant capacity. In turn, AL indices could benefit by adopting the methodological rigor formalized within BA composites, such as applying biomarker down-selection criteria.

20 December 2024 in ACS Nano
Verified
Journal Article
Open access
RWRuixuan Wang
Ruixuan Wang
WHWaylon J. Hastings
Waylon J. Hastings
JSJulian G. Saliba
Julian G. Saliba
DBDuran Bao
Duran Bao
YHYuanyu Huang
Yuanyu Huang
BNBo Ning
Bo Ning
Spatial omics methods are extensions of traditional histological methods that can illuminate important biomedical mechanisms of physiology and disease by examining the distribution of biomolecules, including nucleic acids, proteins, lipids, and metabolites, at microscale resolution within tissues or individual cells. Since, for some applications, the desired resolution for spatial omics approaches the nanometer scale, classical tools have inherent limitations when applied to spatial omics analyses, and they can measure only a limited number of targets. Nanotechnology applications have been instrumental in overcoming these bottlenecks. When nanometer-level resolution is needed for spatial omics, super resolution microscopy or detection imaging techniques, such as mass spectrometer imaging, are required to generate precise spatial images of target expression. DNA nanostructures are widely used in spatial omics for purposes such as nucleic acid detection, signal amplification, and DNA barcoding for target molecule labeling, underscoring advances in spatial omics. Other properties of nanotechnologies include advanced spatial omics methods, such as microfluidic chips and DNA barcodes. In this review, we describe how nanotechnologies have been applied to the development of spatial transcriptomics, proteomics, metabolomics, epigenomics, and multiomics approaches. We focus on how nanotechnology supports improved resolution and throughput of spatial omics, surpassing traditional techniques. We also summarize future challenges and opportunities for the application of nanotechnology to spatial omics methods.